FindTrial
Sign In

Precise treatment of pancreatic cancer based on three-dimensional visualization technology

Precise treatment of pancreatic cancer based on three-dimensional visualization technology

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030191
Enrollment
Unknown
Registered
2020-02-25
Start date
2019-05-17
Completion date
Unknown
Last updated
2020-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer

Interventions

Case series:Nil

Sponsors

Wannan Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients who have been diagnosed with pancreatic cancer by ultrasonography CTMRI and tumor markers; 2. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) contraindications of angiography and contrast agents; (2) those with bleeding or coagulation dysfunction that cannot be corrected and have obvious bleeding tendency; (3) massive abdominal effusion and multiple systemic metastases; (4) poor systemic condition with multiple organ failure.

Design outcomes

Primary

MeasureTime frame
OS;—

Countries

China

Contacts

Public ContactWang Xiaoming

Wannan Medical College

keailizishanchun@126.com+86 0553 5739205

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026